Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Glaucoma > Blue light pupillary responses differ between LHON and primary open-angle glaucoma
  • Glaucoma

Blue light pupillary responses differ between LHON and primary open-angle glaucoma

Ophthalmology 360

Key Takeaways

  1. Patients with Leber hereditary optic neuropathy showed stronger blue light–mediated pupillary responses than those with primary open-angle glaucoma despite similar structural and functional damage.
  2. Post-illumination pupillary response after blue light stimulation differed significantly between POAG and the other groups.
  3. Findings suggest preserved intrinsically photosensitive retinal ganglion cell function in LHON compared with POAG.

Despite having similar degrees of macular structural and functional damage, patients with Leber hereditary optic neuropathy (LHON) demonstrated better blue light–mediated pupillary responses and post-illumination pupillary response than those with primary open-angle glaucoma (POAG), according to a study.

The study included 8 patients with POAG, 9 patients with LHON, and 14 healthy controls. Participants with POAG had Humphrey visual field mean deviation, circumpapillary retinal nerve fiber layer thickness, and ganglion cell/inner plexiform layer thickness comparable to those measured in the LHON group.

Pupillary responses were measured with a handheld electronic pupillometer, recording the contralateral pupil during a 7-second baseline, 10 seconds of red and blue light stimulation, and 40-second post-stimulation periods for each.

The ratio of pupil diameter measured 6 seconds after blue light offset, but not after red light offset, was significantly larger in POAG patients than in the other groups.

In addition, the difference between baseline pupil diameter and the mean pupil diameter during the 30-second post-illumination period was greater with blue versus red stimulation in POAG patients compared with both LHON patients and controls. Maintenance of pupillary constriction during blue light stimulation was also significantly reduced in the POAG group.

Reference

Iwaki Y, Ueda K, Mori S, et al. Difference in pupillary response to red and blue color stimuli between glaucoma and Leber hereditary optic neuropathy patients with comparable central visual dysfunction. Doc Ophthalmol. 2026;doi: 10.1007/s10633-025-10071-w. Epub ahead of print. PMID: 41553591.

Share

Related Content

  • Glaucoma

Poor sleep quality linked to glaucoma severity in older adults

  • Glaucoma

Glaucoma drainage devices provide meaningful IOP control in pediatric glaucoma

  • Glaucoma

Expanding the glaucoma treatment landscape with FLIGHT technology

  • Glaucoma

Geographic differences in glaucoma care raise concerns about equitable access

  • Glaucoma

Study finds significant IOP reductions with iDose TR and MIGS procedures

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon